Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors
摘要:
We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor Vila inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway. (c) 2005 Elsevier Ltd. All rights reserved.
A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability.
[wherein R
1a
, R
1b
, R
1c
and R
1d
each independently represent hydrogen, etc.; R
2
represents optionally substituted phenyl, etc.; R
3
represents optionally substituted C6-10 aryl, etc.; and Z
1
and Z
2
each independently represent hydrogen]
[EN] TRIORTHOGONAL REAGENTS FOR DUAL PROTEIN CONJUGATION<br/>[FR] RÉACTIFS TRIORTHOGONAUX POUR LA CONJUGAISON DE PROTÉINES MIXTES
申请人:UNIV MINNESOTA
公开号:WO2015057863A1
公开(公告)日:2015-04-23
The present invention relates to triorthogonal reagents useful for site-specifically modifying a protein with two orthogonal groups that can be subsequently functionalized in a single one-pot procedure. This approach relies on the selective tagging of proteins containing an appended farnesyltransferase or geranylgeranyltransferase I substrate sequence. The incorporation of a bifunctional ethynyl-hydroxybenzaldehyde into the farnesyl or geranylgeranyl group facilitates the facile labeling of proteins with two different moieties.
Design, Synthesis, and Operation of Small Molecules That Walk along Tracks
作者:Max von Delius、Edzard M. Geertsema、David A. Leigh、Dan-Tam D. Tang
DOI:10.1021/ja106486b
日期:2010.11.17
directional bias in the distribution of the walker on the track. The different length walker molecules exhibit very different walking behaviors: Systems n = 2 and 3 cannot actually "walk" along the track because their stride lengths are too short to bridge the internal footholds. The walkers with longer spacers (n = 4, 5, and 8) do step up and down the track repeatedly, but a directional bias under the acid-redox
A Compound represented by the following general formula (1):
wherein R
1a
, R
1b
, R
1c
and R
1d
each independently represent hydrogen, etc.; R
2
represents optionally substituted phenyl, etc.; R
3
represents optionally substituted C6-10 aryl, etc.; and Z
1
and Z
2
each independently represent hydrogen
or salts thereof or hydrates of the foregoing.
TRIORTHOGONAL REAGENTS FOR DUAL PROTEIN CONJUGATION
申请人:REGENTS OF THE UNIVERSITY OF MINNESOTA
公开号:US20160271261A1
公开(公告)日:2016-09-22
The present invention relates to triorthogonal reagents useful for site-specifically modifying a protein with two orthogonal groups that can be subsequently functionalized in a single one-pot procedure. This approach relies on the selective tagging of proteins containing an appended farnesyltransferase or geranylgeranyltransferase I substrate sequence. The incorporation of a bifunctional ethynyl-hydroxybenzaldehyde into the farnesyl or geranylgeranyl group facilitates the facile labeling of proteins with two different moieties.